Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03616886
Title Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC (SYNERGY)
Acronym SYNERGY
Recruitment Active, not recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Jules Bordet Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
Institut Jules Bordet Brussels 1000 Belgium Details
Cliniques universitaires Saint Luc Bruxelles Belgium Details
Grand Hôpital de Charleroi Charleroi Belgium Details
UZ Leuven Gasthuisberg Leuven Belgium Details
CHU UCL Namur Sainte-Elisabeth Namur 5000 Belgium Details
Clinique St Pierre Ottignies Belgium Details
Sint-Augustinus, GZA Ziekenhuizen Wilrijk Belgium Details
CHU Besançon Besançon France Details
Institut Bergonié Bordeaux France Details
Centre Georges François Leclerc Dijon France Details
Institut Paoli-Calmettes Marseille France Details
Centre Antoine Lacassagne Nice France Details
Institut Curie Paris France Details
CHU Poitiers Poitiers 86021 France Details
Centre Henri Becquerel Rouen France Details
Hôpitaux Universitaires de Strasbourg Strasbourg France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field